Fatty liver and fatty pancreas study
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at people with fatty liver disease linked to metabolism. It checks if they also have fat in the pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with fatty liver disease linked to metabolism (MAFLD)
- You do not drink more than 1 small glass of alcohol per day (for women) or 2 small glasses (for men)
- You do not have other liver diseases like hepatitis B or C, autoimmune hepatitis, or celiac disease
- You are not pregnant or breastfeeding, and do not have active cancer or kidney failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special ultrasound technique (eco-elastography) to measure fat inside the pancreas and see how it relates to metabolic syndrome and the cells that produce insulin. It might help understand why some people develop diabetes or other metabolic issues.
This study uses scans to measure how common “fatty change” is in the pancreas. It then looks at whether fatty change is related to specific features of pancreatic cysts (and may also include healthy people).
This study aims to create a score to measure fat inside the pancreas using imaging. It may help understand how pancreatic fat relates to health conditions.
This study checks how often people with Crohn's or ulcerative colitis also have fatty liver disease. It uses a painless scan to measure liver stiffness and fat. If you have IBD, you may join to help researchers learn about the link between these conditions.
This study looks at how the liver's immune environment changes in people with non-alcoholic fatty liver disease (NAFLD) that has progressed to significant scarring. Researchers will use a liver biopsy to understand the inflammation better, which may lead to new treatments.
This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.
Hear when a new Exocrine Pancreatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.